1. Home
  2. LUNG vs ALAR Comparison

LUNG vs ALAR Comparison

Compare LUNG & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • ALAR
  • Stock Information
  • Founded
  • LUNG 1995
  • ALAR 2013
  • Country
  • LUNG United States
  • ALAR Israel
  • Employees
  • LUNG N/A
  • ALAR N/A
  • Industry
  • LUNG Industrial Specialties
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • LUNG Health Care
  • ALAR Technology
  • Exchange
  • LUNG Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • LUNG 106.3M
  • ALAR 85.8M
  • IPO Year
  • LUNG 2020
  • ALAR 2018
  • Fundamental
  • Price
  • LUNG $3.09
  • ALAR $11.89
  • Analyst Decision
  • LUNG Buy
  • ALAR Strong Buy
  • Analyst Count
  • LUNG 6
  • ALAR 1
  • Target Price
  • LUNG $11.53
  • ALAR $15.00
  • AVG Volume (30 Days)
  • LUNG 408.2K
  • ALAR 101.4K
  • Earning Date
  • LUNG 07-30-2025
  • ALAR 08-25-2025
  • Dividend Yield
  • LUNG N/A
  • ALAR N/A
  • EPS Growth
  • LUNG N/A
  • ALAR N/A
  • EPS
  • LUNG N/A
  • ALAR 0.07
  • Revenue
  • LUNG $87,473,000.00
  • ALAR $30,581,000.00
  • Revenue This Year
  • LUNG $18.02
  • ALAR N/A
  • Revenue Next Year
  • LUNG $18.17
  • ALAR $12.28
  • P/E Ratio
  • LUNG N/A
  • ALAR $18.45
  • Revenue Growth
  • LUNG 19.84
  • ALAR 4.67
  • 52 Week Low
  • LUNG $2.50
  • ALAR $5.45
  • 52 Week High
  • LUNG $9.37
  • ALAR $28.43
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 50.76
  • ALAR 49.14
  • Support Level
  • LUNG $3.03
  • ALAR $11.31
  • Resistance Level
  • LUNG $3.88
  • ALAR $12.45
  • Average True Range (ATR)
  • LUNG 0.34
  • ALAR 0.61
  • MACD
  • LUNG 0.05
  • ALAR -0.19
  • Stochastic Oscillator
  • LUNG 39.23
  • ALAR 26.85

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

Share on Social Networks: